CAS Number: 1313725-88-0 Chemical Name / IUPAC: (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine Molecular Formula: C₁₇H₁₅N₉ Molecular Weight: 345.36 g/mol Category: Anticancer / Antineoplastic API; selective MET tyrosine kinase inhibitor Indication/Use: Treatment of MET exon 14 skipping-altered non-small cell lung cancer (NSCLC); marketed as Orpathys® in China (conditional approval); under development globally by AstraZeneca and HUTCHMED Purity/Assay: Typically ≥98% (HPLC) for API grade; specify your batch (e.g., 98.44% or higher) Appearance: Usually white to off-white powder Package: e.g., 1g, 5g, 10g, 100g, 1kg, or bulk (customizable) Storage: Sealed, cool, dry place; protect from light Other Specs: Solubility (e.g., in DMSO), stability data, GMP/CEP status if applicable, manufacturer certifications, COA/MSDS availability
